Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)

Stopped Due to a change in the development program, the study was closed prematurely.

Conditions

• Uterine Fibroids

Interventions

• DRUG: Vilaprisan (BAY1002670)
• DRUG: Placebo

Sponsor

Bayer